OCUL Ocular Therapeutix Corp: Net earnings per share growth forecast for next year

OCUL (ocutx.com) - company brandmark

Ocular Therapeutix develops glaucoma therapy implants designed to replace eye drops. Management is focusing on the commercialization of long-acting drugs. The company is expanding its internal pipeline through investment alliances without engaging in M&A transactions. The -3.30 mark is a current indicator that reflects the target EPS growth rate for the following year on the chart.

OCUL: Ocular Pharma Expected earnings per share growth for next year 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Ocular Therapeutix, Inc. (OCUL)

- price and consensus price forecast:
Basic company analysis:OCUL, Ocular Therapeutix
Core merchandise of ocutx.com

For Ocular Therapeutix (OCUL), which develops innovative ophthalmological drug delivery systems, this indicator reflects the analysts' consensus forecast for earnings per share changes next year. Analyzing the trend in Ocular Therapeutix (OCUL) EPS forecast revisions allows for an assessment of future profitability amid the launch of new drugs, helping investors balance potential asset appreciation against the risk of overpaying for inflated expectations.

Competitor analysis for Ocular Therapeutix

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|Earnings growth forecast for next year Harrow Corp HROW|VRDN - Net earnings per share growth forecast for next year|LENZ (LENZ Therapeutics) - Projected earnings per share growth rate for next year|Oculis (OCS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year EYPT (EyePoint Pharmaceuticals Inc)|Net earnings per share growth forecast for next year Kodiak Sciences Inc|Expected net earnings per share growth next year aldeyra.com ALDX|Earnings growth forecast for next year KALA|IRD - Expected net earnings per share growth next year|Earnings growth forecast for next year OKYO (OKYO Pharma Limited)|ADVM - Expected earnings per share growth for next year|OTLK: Expected earnings per share growth for next year|CLSD (Clearside) - Projected earnings per share growth rate for next year|NBY: Earnings growth forecast for next year|Kiora Pharma (KPRX) - Earnings growth forecast for next year|ALIM (alimerasciences.com) - Earnings growth forecast for next year|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)